Safety and Early Oncologic Effectiveness of Primary Robotic Retroperitoneal Lymph Node Dissection for Nonseminomatous Germ Cell Testicular Cancer-Reference-Cited by-同舟云学术

Safety and Early Oncologic Effectiveness of Primary Robotic Retroperitoneal Lymph Node Dissection for Nonseminomatous Germ Cell Testicular Cancer

Published:2017-03 Issue:3 Volume:71 Page:476-482
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Pearce Shane M.,Golan Shay,Gorin Michael A.,Luckenbaugh Amy N.,Williams Stephen B.,Ward John F.,Montgomery Jeffrey S.,Hafez Khaled S.,Weizer Alon Z.,Pierorazio Phillip M.,Allaf Mohamad E.,Eggener Scott E.

Publisher

Elsevier BV

Subject

Urology

Reference36 articles.

1. Clinical practice guidelines in oncology: testicular cancer;Motzer;J. Natl. Compr. Cancer Netw.,2009

2. Patterns of relapse in patients with clinical stage I testicular cancer managed with active surveillance;Kollmannsberger;J. Clin. Oncol.,2015

3. Guidelines on testicular cancer: 2015 update;Albers;Eur. Urol.,2015

4. Laparoscopic retroperitoneal lymph node dissection in a patient with stage 1 testicular carcinoma;Rukstalis;J. Urol.,1992

5. Oncologic efficacy of laparoscopic RPLND in treatment of clinical stage I nonseminomatous germ cell testicular cancer;Nielsen;Urology,2007

Cited by 93 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Contemporary short‐term peri‐operative outcomes of open primary retroperitoneal lymph node dissection;BJU International;2024-09-03

2. Retroperitoneal Lymph Node Dissection;Urologic Clinics of North America;2024-08

3. Primary retroperitoneal lymph node dissection for metastatic non‐seminomatous germ cell tumours: outcomes and adjuvant chemotherapy;BJU International;2024-07-05

4. Unilateral Post-Chemotherapy Robot-Assisted Retroperitoneal Lymph Node Dissection for Stage II Non-Seminomatous Germ Cell Tumors: Sexual and Reproductive Outcomes;Cancers;2024-06-15

5. Lymph Node Dissection in Testicular Cancer: The State of the Art and Future Perspectives;Current Oncology Reports;2024-03-02